Cutimed® Sorbact® Hydroactive B

is a bacteria-binding, absorbent gel dressing with an adhesive border. Cutimed Sorbact Hydroactive B combines a highly absorbent hydropolymer matrix with bacteria-binding Sorbact mesh (Sorbact acetate fabric coated with DACC™) and is covered by a semi-permeable polyurethane film. The fixation border is made of a latex free adhesive hydrogel.

  • Treats and helps to prevent wound infection
  • Safe removal of bacteria, fungi and endotoxins 
  • Effective against most common resistant pathogens

Intended Purpose

Cutimed Sorbact Hydroactive B is indicated for use in the management of low to moderate exuding partial to full thickness wounds (including clean, colonised, contaminated, or infected wounds): chronic wounds (venous and arterial ulcers, diabetic ulcers and pressure ulcers), postoperative dehisced wounds and traumatic wounds.

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 4 days.

Product benefits

Symbol of a shield representing infection prevention

Treats and helps to prevent wound infection

Sorbact Technology dressings reduce bioburden and support effective wound healing, with low risk of allergies1, 2, 3, 4, 5, 6.
Symbol of looped threads to visualize the term 'pacify'

Safe removal of bacteria, fungi and endotoxins

Sorbact Technology dressings irreversibly bind and remove bacteria, without the release of active agents to the wound5. Development of bacterial or fungal resistance is not expected. 
Symbol showing crossed out pathogens, which stands for effectiveness against the most common resistant ones

Effective against most common resistant pathogens

In vitro tests show that Sorbact Technology dressings are able to inhibit the growth of the Top 5 World Health Organization (WHO) pathogens7.
Symbol of water circulation to visualize effective moisture balance

Maintains a moist wound environment

Helps to maintain a moist wound environment and supports moist wound healing. 
Symbol showing the gentlest method of cleaning wounds

Supports autolytic debridement

Autolytic debridement faciliates the wound healing process. 

Product facts




Low to moderate

How to use

Usage instruction for Cutimed Hydroactive B
1. Clean the wound as usual.
2. Select an appropriate dressing according to wound size. For best results, make sure Cutimed Sorbact Hydroactive B overlaps the wound margins by at least 2 cm.
3. Remove the protective film and apply the green adhesive side of the dressing to the wound.
4. Depending on the wound location it may be appropriate to apply additional dressing fixation.
5. Cutimed Sorbact Hydroactive B should be changed as often as dictated by the wound condition. As with all absorbent dressings, monitoring is required to ensure the dressing does not dry out and adhere to the wound. The dressing should be changed when it becomes cloudy or opaque from fluid absorption. At the latest after 4 days or if the exudate has reached 1 cm from the edge.
6. In wounds that show signs of clinical infection, a more frequent wound inspection is advised. In these cases, an appropriate systemic treatment should be considered.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s Instructions for Use (IFU).

Product specifications

Essity Product Code
Pack Quantity
PIP Code
Cutimed® Sorbact® Hydroactive B 7993300 7 cm x 8.5 cm 10 1 ELY500 374-5023
Cutimed® Sorbact® Hydroactive B 7993302 14 cm x 14 cm 10 1 ELY501 374-5031
Cutimed® Sorbact® Hydroactive B 7993303 19 cm x 19 cm 10 1 ELY502 374-5049
Cutimed® Sorbact® Hydroactive B 7993304 14 cm x 24 cm 10 1 ELY503 374-5056

Medical References

1 Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.
2 Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.
3 Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.
4 Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.
5 Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.
6 Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.
7 Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006).

Clinical Evidence

On this page, you can view and explore a selection of clinical studies that underline the performance of the Cutimed portfolio.

Discover more

Instruction for use

Please make sure to always follow the instructions for use, including the safety information provided with the product. Not at hand? Find the needed safety information in this database!

Cutimed IFUs